Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-16

Clinical Trial Update: A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 trial investigating lorcaserin hydrochloride for smoking cessation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorcaserin hydrochloride (lorcaserin hydrochloride)

Snippet

Sponsor: Arena Pharmaceuticals | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16